Excellent prognosis of patients with intermediate-risk neuroblastoma and residual tumor postchemotherapy-Reference-Cited by-同舟云学术

Excellent prognosis of patients with intermediate-risk neuroblastoma and residual tumor postchemotherapy

Published:2018-09 Issue:9 Volume:53 Page:1761-1765
ISSN:0022-3468
Container-title:Journal of Pediatric Surgery
language:en
Short-container-title:Journal of Pediatric Surgery

Author:

Amano Hizuru,Uchida Hiroo,Tanaka Yujiro,Tainaka Takahisa,Mori Makiko,Oguma Eiji,Kishimoto Hiroshi,Kawashima Hiroshi,Arakawa Yuki,Hanada Ryoji,Koh Katsuyoshi

Publisher

Elsevier BV

Subject

General Medicine,Pediatrics, Perinatology and Child Health,Surgery

Reference21 articles.

1. Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma;Cozzi;World J Surg,2013

2. A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening;Tanaka;Pediatr Blood Cancer,2010

3. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study;Yoneda;Med Pediatr Oncol,2001

4. Long-term follow-up results of the observation program for neuroblastoma detected at 6-month mass screening;Arakawa;J Pediatr,2014

5. Spontaneous regression of localized neuroblastoma detected by mass screening;Yamamoto;J Clin Oncol,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postchemotherapy gross residual tumor in non‐high‐risk neuroblastoma: Clinical significance and the role of adjuvant therapy;Pediatric Blood & Cancer;2022-06-23

2. Clinical implication of residual MIBG‐positive disease in the follow‐up of high‐risk neuroblastoma treated with tandem high‐dose chemotherapy and autologous stem cell transplantation;Pediatric Blood & Cancer;2021-12-10

3. Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification;Pediatric Blood & Cancer;2021-04-07

4. Advances in the Surgical Treatment of Neuroblastoma;Chinese Medical Journal;2018-10-05